🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial aimed to compare QL1706 combined with induction chemotherapy plus...
Status
Recruiting
Location
Fujian Cancer Hospital
Start Date
2025-05-04
Trial ID
NCT06749899
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Multiple Locations
Start Date
2000-06-07
Trial ID
NCT00544414
This is a phase 3, multi-center, randomized controlled trial, with the purp...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2021-08-01
Trial ID
NCT04907370
This study is a multicenter, randomized, controlled phase III clinical tria...
Status
Recruiting
Location
The First Affiliated Hospital of Guangxi Medical University
Start Date
2026-03-05
Trial ID
NCT07459296
This is a Phase II, multicenter, double-blind, randomized study designed to...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-07-01
Trial ID
NCT04611776
Treatments Being Tested
This trial aims to study the role of Ivonescimab combined with chemoradioth...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2026-08-01
Trial ID
NCT07064902
Treatments Being Tested
Through randomized controlled phase III multicenter clinical trials, GP ind...
Status
Unknown
Location
Cancer Hospital of Guizhou Medical University
Start Date
2018-07-21
Trial ID
NCT03604965
The purpose of this study is to compare the efficacy and safety of sequenti...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2018-01-01
Trial ID
NCT03366415
Nimotuzumab is an IgG1 humanized monoclonal antibody that recognized an epi...
Status
Recruiting
Location
People's Hospital of Baise
Start Date
2022-12-01
Trial ID
NCT05717790
Treatments Being Tested
This study aims to explore the efficacy and safety of risk-adapted adjuvant...
Status
Recruiting
Location
Fudan Universtiy Shanghai Cancer Center
Start Date
2026-08
Trial ID
NCT07762976
Treatments Being Tested